Multiple Myeloma

Multiple Myeloma is a cancer of the plasma cells, which normally is involved in antibody production. Discover the latest research on Multiple Myeloma here.

February 24, 2021

CAR Ts and BiTEs Shine in Multiple Myeloma.

Cancer Discovery
February 24, 2021

Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma.

Nature Medicine
Matteo C Da ViàLeo Rasche
February 24, 2021
Open Access

Coexisting Spine Lesions on Whole Spine T2 Sagittal MRI in Evaluating Spinal Degenerative Disease.

Journal of Korean Medical Science
Jae Hong HaJae Hyup Lee
February 24, 2021

Synchronous detection of multiple myeloma and acute myeloid leukemia: A diagnostic and therapeutic challenge.

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Senem MaralMesude Falay
February 24, 2021

A 77-Year-Old Man with Multiple Myeloma and a Lytic Bone Lesion.

The American Journal of Medicine
Joseph Sassine, Dimitrios P Kontoyiannis
February 24, 2021

MicroRNA-365 induces apoptosis and inhibits invasion of human myeloma cells by targeting homeobox A9 (HOXA9).

Environmental Toxicology and Pharmacology
Ying GaoLiMin Hou
February 23, 2021

Improving rates of venous thromboembolism prophylaxis in multiple myeloma patients on immunomodulatory drugs through a pharmacy-based system.

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Aric ParnesNancy Berliner
February 23, 2021

Real-world treatment patterns in relapsed/refractory multiple myeloma: Clinical and economic outcomes in patients treated with pomalidomide or daratumumab.

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Joshua RichterDrishti Shah
February 23, 2021

Bioinformatic gene expression analysis demonstrates a limited number of multiple myeloma specific therapeutic targets.

Leukemia & Lymphoma
Murari RameshEdward Abadir
February 23, 2021

First experience of the use of a generic of plerixafor in peripheral blood stem cell mobilization in multiple myeloma and lymphoma patients.

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
M A BekadjaN Yafour
February 23, 2021
Open Access

Assessment and Management of Cardiotoxicity in Hematologic Malignancies.

Disease Markers
Anca BojanAndrada Parvu
February 23, 2021
Open Access

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma.

Therapeutic Advances in Hematology
Larysa SanchezAjai Chari
February 23, 2021

Updates on Therapeutic Advancements in Relapsed or Refractory Multiple Myeloma: Highlights From SOHO 2020.

Journal of the Advanced Practitioner in Oncology
February 23, 2021
Case Report
Open Access

Intracranial Plasmacytoma Mimicking a Cavernous Sinus Meningioma.

Stephen J BordesBadih Adada
February 23, 2021
Open Access

Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis.

Frontiers in Oncology
Gregory P Kaufman, Claudio Cerchione
February 23, 2021

Post-Transplant Maintenance Treatment Options in Multiple Myeloma.

Oncology and Therapy
Dhauna Karam, Shaji K Kumar
February 23, 2021

Life-long Passion for Antiviral Research and Drug development: 80th Birthday of Prof. Dr. Erik De Clercq.

Biochemical Pharmacology
Guangdi LiLi Tan

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Adult Polyglucosan Body Disease

Adult polyglucosan body disease (APBD) is a rare autosomal recessive disease characterized by defects in the glycogen brancher enzyme 1 (GBE1) gene. Discover the latest research on APBD here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

© 2021 Meta ULC. All rights reserved